ArticleMedical & biological engineering & computing2026
An explainable ensemble for diabetic retinopathy grading with a novel confidence quality factor and configurable heatmaps.
Article in Medical & biological engineering & computing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- OrdPrune-KD: An Ordinal-Consistency-Based Model Compression Framework for Diabetic Retinopathy Grading.Sensors (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While current artificial intelligence (AI) tools aid in detecting diabetic retinopathy (DR), they face significant challenges that limit their clinical utility. Most are restricted to binary (referable vs. non-referable) screening and operate as “black boxes,” lacking the detailed, transparent explanations required for diagnostic confidence. This study addresses these gaps by introducing a novel, explainable ensemble-based approach for detailed DR grading. Our system utilizes a parallel ensemble of two efficient deep learning networks, EfficientNetV2 and ConvNeXt, to perform a full five-class international clinical diabetic retinopathy (ICDR) classification. The proposed model achieves state-of-the-art performance, with 96.7% accuracy and an Area Under the Curve (AUC) over 96% for all classes on a public dataset. More importantly, it provides a comprehensive diagnostic report designed to enhance clinical trust and utility. This report features multiple, configurable superimposed heatmaps, two probability-ordered diagnostic suggestions, and a novel quality factor that estimates the confidence of the prediction. By offering richer, more transparent, and interactive explanations, our system moves beyond simple screening to function as a valuable diagnostic assistance tool for ophthalmologists and other healthcare professionals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.